WO2003068954A8 - Mikroorganismus zur gentherapeutischen behandlung proliferativer erkrankungen - Google Patents
Mikroorganismus zur gentherapeutischen behandlung proliferativer erkrankungenInfo
- Publication number
- WO2003068954A8 WO2003068954A8 PCT/DE2003/000470 DE0300470W WO03068954A8 WO 2003068954 A8 WO2003068954 A8 WO 2003068954A8 DE 0300470 W DE0300470 W DE 0300470W WO 03068954 A8 WO03068954 A8 WO 03068954A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- microorganism
- nucleotide sequence
- specific
- optionally
- expression
- Prior art date
Links
- 244000005700 microbiome Species 0.000 title abstract 9
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000002068 genetic effect Effects 0.000 title 1
- 230000002062 proliferating effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000002773 nucleotide Substances 0.000 abstract 5
- 125000003729 nucleotide group Chemical group 0.000 abstract 5
- 230000004913 activation Effects 0.000 abstract 3
- 210000004027 cell Anatomy 0.000 abstract 2
- 102000004506 Blood Proteins Human genes 0.000 abstract 1
- 108010017384 Blood Proteins Proteins 0.000 abstract 1
- 230000009089 cytolysis Effects 0.000 abstract 1
- 210000000172 cytosol Anatomy 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 210000002381 plasma Anatomy 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000032258 transport Effects 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01031—Beta-glucuronidase (3.2.1.31)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/16—Exonucleases active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters (3.16)
- C12Y301/16001—Spleen exonuclease (3.1.16.1), i.e. 5->3 exoribonuclease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
Abstract
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003568069A JP2005517405A (ja) | 2002-02-14 | 2003-02-13 | 増殖性疾患の遺伝子療法的治療のための微生物 |
BRPI0307722A BRPI0307722A2 (pt) | 2002-02-14 | 2003-02-13 | microorganismo envolvido |
MXPA04007934A MXPA04007934A (es) | 2002-02-14 | 2003-02-13 | Microorganismo envuelto. |
AU2003206663A AU2003206663B2 (en) | 2002-02-14 | 2003-02-13 | Microorganism for genetic therapeutic treatment of proliferative diseases |
KR10-2004-7012866A KR20040103941A (ko) | 2002-02-14 | 2003-02-13 | 증식성 질병의 유전자 치료를 위한 미생물 |
YU72404A RS72404A (en) | 2002-02-14 | 2003-02-13 | Microorganism for genetic therapeutic treatment of proliferative diseases |
CA002513198A CA2513198A1 (en) | 2002-02-14 | 2003-02-13 | Microorganism for genetic therapeutic treatment of proliferative diseases |
EP03704314A EP1474519A2 (de) | 2002-02-14 | 2003-02-13 | Mikroorganismus zur gentherapeutischen behandlung proliferativer erkrankungen |
DE2003190506 DE10390506D2 (de) | 2002-02-14 | 2003-02-13 | Ummantelter Mikroorganismus |
US10/504,944 US20050244374A1 (en) | 2002-02-14 | 2003-02-13 | Enveloped miroorganism |
NZ535310A NZ535310A (en) | 2002-02-14 | 2003-02-13 | Microorganism for genetic therapeutic treatment of proliferative diseases |
IL16355303A IL163553A0 (en) | 2002-02-14 | 2003-08-13 | Microorganism for genetic therapeutic treatment ofproliferative diseases |
NO20043800A NO20043800L (no) | 2002-02-14 | 2004-09-10 | Mikroorganisme for genetisk terapetuisk behandling av proliferativ sykdom |
HRP20040832 HRP20040832A2 (en) | 2002-02-14 | 2004-09-14 | Microorganism for genetic therapeutic treatment of proliferative diseases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10206325.7 | 2002-02-14 | ||
DE10206325A DE10206325A1 (de) | 2002-02-14 | 2002-02-14 | Ummantelter Mikroorganismus |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2003068954A2 WO2003068954A2 (de) | 2003-08-21 |
WO2003068954A3 WO2003068954A3 (de) | 2003-10-16 |
WO2003068954A8 true WO2003068954A8 (de) | 2005-10-13 |
Family
ID=27674670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2003/000470 WO2003068954A2 (de) | 2002-02-14 | 2003-02-13 | Mikroorganismus zur gentherapeutischen behandlung proliferativer erkrankungen |
Country Status (19)
Country | Link |
---|---|
US (1) | US20050244374A1 (de) |
EP (1) | EP1474519A2 (de) |
JP (1) | JP2005517405A (de) |
KR (1) | KR20040103941A (de) |
CN (1) | CN1646693A (de) |
AU (1) | AU2003206663B2 (de) |
BR (1) | BRPI0307722A2 (de) |
CA (1) | CA2513198A1 (de) |
DE (2) | DE10206325A1 (de) |
HR (1) | HRP20040832A2 (de) |
IL (1) | IL163553A0 (de) |
MX (1) | MXPA04007934A (de) |
NO (1) | NO20043800L (de) |
NZ (1) | NZ535310A (de) |
PL (1) | PL372901A1 (de) |
RS (1) | RS72404A (de) |
RU (1) | RU2004127459A (de) |
WO (1) | WO2003068954A2 (de) |
ZA (1) | ZA200407358B (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008504822A (ja) * | 2004-06-29 | 2008-02-21 | アンチキャンサー インコーポレーテッド | 癌選択的栄養要求株 |
CN112423785A (zh) | 2018-07-19 | 2021-02-26 | 瑞泽恩制药公司 | 双特异性抗BCMAx抗CD3抗体及其用途 |
US11519007B2 (en) | 2019-02-22 | 2022-12-06 | Arizona Board Of Regents On Behalf Of Arizona State University | Tumor-navigating, self-eradicating, trail-armed salmonella for precision cancer therapy |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19720761A1 (de) * | 1997-05-07 | 1998-11-12 | Schering Ag | Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung |
-
2002
- 2002-02-14 DE DE10206325A patent/DE10206325A1/de not_active Ceased
-
2003
- 2003-02-13 MX MXPA04007934A patent/MXPA04007934A/es not_active Application Discontinuation
- 2003-02-13 JP JP2003568069A patent/JP2005517405A/ja active Pending
- 2003-02-13 EP EP03704314A patent/EP1474519A2/de not_active Withdrawn
- 2003-02-13 KR KR10-2004-7012866A patent/KR20040103941A/ko not_active Application Discontinuation
- 2003-02-13 RS YU72404A patent/RS72404A/sr unknown
- 2003-02-13 CA CA002513198A patent/CA2513198A1/en not_active Abandoned
- 2003-02-13 RU RU2004127459/13A patent/RU2004127459A/ru unknown
- 2003-02-13 BR BRPI0307722A patent/BRPI0307722A2/pt not_active IP Right Cessation
- 2003-02-13 WO PCT/DE2003/000470 patent/WO2003068954A2/de active Application Filing
- 2003-02-13 CN CNA038082446A patent/CN1646693A/zh active Pending
- 2003-02-13 AU AU2003206663A patent/AU2003206663B2/en not_active Ceased
- 2003-02-13 NZ NZ535310A patent/NZ535310A/en unknown
- 2003-02-13 DE DE2003190506 patent/DE10390506D2/de not_active Expired - Lifetime
- 2003-02-13 PL PL03372901A patent/PL372901A1/xx not_active Application Discontinuation
- 2003-02-13 US US10/504,944 patent/US20050244374A1/en not_active Abandoned
- 2003-08-13 IL IL16355303A patent/IL163553A0/xx unknown
-
2004
- 2004-09-10 NO NO20043800A patent/NO20043800L/no not_active Application Discontinuation
- 2004-09-14 ZA ZA200407358A patent/ZA200407358B/xx unknown
- 2004-09-14 HR HRP20040832 patent/HRP20040832A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2003206663B2 (en) | 2007-11-01 |
KR20040103941A (ko) | 2004-12-09 |
AU2003206663A1 (en) | 2003-09-04 |
CA2513198A1 (en) | 2003-08-21 |
DE10206325A1 (de) | 2003-09-04 |
BRPI0307722A2 (pt) | 2017-07-04 |
RS72404A (en) | 2006-12-15 |
JP2005517405A (ja) | 2005-06-16 |
WO2003068954A3 (de) | 2003-10-16 |
US20050244374A1 (en) | 2005-11-03 |
EP1474519A2 (de) | 2004-11-10 |
MXPA04007934A (es) | 2005-11-23 |
HRP20040832A2 (en) | 2004-12-31 |
NZ535310A (en) | 2008-04-30 |
RU2004127459A (ru) | 2005-05-10 |
PL372901A1 (en) | 2005-08-08 |
DE10390506D2 (de) | 2005-01-13 |
AU2003206663B9 (en) | 2003-09-04 |
WO2003068954A2 (de) | 2003-08-21 |
CN1646693A (zh) | 2005-07-27 |
ZA200407358B (en) | 2005-11-18 |
IL163553A0 (en) | 2005-12-18 |
NO20043800L (no) | 2004-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Margottin et al. | Participation of the TATA factor in transcription of the yeast U6 gene by RNA polymerase C | |
Berrocal-Tito et al. | Trichoderma atroviride PHR1, a fungal photolyase responsible for DNA repair, autoregulates its own photoinduction | |
Hübscher et al. | Replication of the lagging strand: a concert of at least 23 polypeptides | |
ATE323169T1 (de) | Plasmid zur verabreichung von nukleine säuren und verwendungsverfahren | |
AU3461097A (en) | Novel VEGF-like factor | |
MX9705039A (es) | Genes y proteinas de muerte celular programada. | |
WO2002042445A3 (en) | Differentiated cells suitable for human therapy | |
EP0919622A3 (de) | Oberflächenlokalisierte Expression von Enzymen in gengesteuerter Prodrugtherapie | |
WO2003023000A3 (en) | Linear dna fragments for gene expression | |
WO2001002019A3 (en) | Control of gene expression | |
WO2003045427A3 (en) | Pharmaceutical composition for inducing an immune response in a human or animal | |
MX9708854A (es) | Terapia de genes para regulacion de celulas efectoras. | |
WO2000056866A3 (en) | Akt-3 nucleic acids, polypeptides, and uses thereof | |
WO2003068954A3 (de) | Mikroorganismus zur gentherapeutischen behandlung proliferativer erkrankungen | |
Meineke et al. | A fungal anticodon nuclease ribotoxin exploits a secondary cleavage site to evade tRNA repair | |
SG93780A1 (en) | Gene manipulation and expression using genomic elements | |
AU2180501A (en) | Novel DNA polymerase inhibitors, mikanolide and dihydromikanolide | |
WO2007089950A3 (en) | Preparations of growth hormone | |
GB0017761D0 (en) | Nucleic acid delivery | |
EP1188835A4 (de) | Vektor für die expression von zwei fremdgenen | |
WO2004024867A3 (en) | Vigilant vector system | |
WO2001025398A3 (en) | Process for inducing functional tolerance to gene transfer products | |
EP0763205A4 (de) | Nukleinsäuresequenzen die lungenzellenspezifishe genexpression kontrollieren | |
WO2004096826A3 (en) | Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna) | |
AU2944100A (en) | Gene therapeutics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: P-724/04 Country of ref document: YU |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1020047012866 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 163553 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2004/007934 Country of ref document: MX Ref document number: 2003568069 Country of ref document: JP Ref document number: 372901 Country of ref document: PL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003704314 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 01349/KOLNP/2004 Country of ref document: IN Ref document number: 1349/KOLNP/2004 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004/07358 Country of ref document: ZA Ref document number: P20040832A Country of ref document: HR Ref document number: 535310 Country of ref document: NZ Ref document number: 2004127459 Country of ref document: RU Ref document number: 2003206663 Country of ref document: AU Ref document number: 200407358 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038082446 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2003704314 Country of ref document: EP |
|
REF | Corresponds to |
Ref document number: 10390506 Country of ref document: DE Date of ref document: 20050113 Kind code of ref document: P |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10390506 Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10504944 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2513198 Country of ref document: CA |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 34/2003 UNDER (81) DELETE "DE" |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
ENP | Entry into the national phase |
Ref document number: 2003206663 Country of ref document: AU Date of ref document: 20030213 Kind code of ref document: B |
|
ENP | Entry into the national phase |
Ref document number: PI0307722 Country of ref document: BR Kind code of ref document: A2 Effective date: 20040816 |